Restructure Information

On September 15, 2019, Purdue Pharma L.P. announced a preliminary agreement to settle the opioid litigation facing the Company.

We’re working toward a settlement that would deliver more than $10 billion in value and address the opioid crisis by, among other things, providing needed funds, as well as millions of doses of lifesaving opioid addiction treatment and overdose reversal medicines.

The settlement is designed to speed the delivery of resources and vital medicines that communities can use to address and abate the opioid crisis.

Purdue is working to garner additional support for the settlement and seeks to implement a final resolution through the federal bankruptcy system.  We are working to emerge from bankruptcy as a public benefit company with a focus on addressing the opioid crisis and established for the benefit of claimants and the American people.

Read our statement Speaking Out Against Systemic Racism here

RECENT NEWS

Purdue Pharma Reaches Agreement With U.S. Department of Justice

-- Agreement resolves DOJ investigations into past marketing practices -- Settlement funds primarily directed to state, local and tribal governments for opioid crisis abatement purposes -- Agreement…

Prescription Drug Safety Network Doubles Student Reach During the 2019-2020 Academic Year

-- 80 percent of students in Purdue Pharma’s sponsored regions reported they felt prepared to avoid prescription drug misuse after completing the course -- In response to an increase in distance…

Purdue Pharma L.P. to Fund Harm Reduction Therapeutics, Inc.’s Development of Over-the-Counter Opioid Overdose Reversal Medication

Lower cost, more accessible medication will help save lives Purdue Pharma L.P. and Harm Reduction Therapeutics, Inc. (HRT) announced today that Purdue will provide up to $6.5 million of additional…

Opinion – Steve Miller: Here’s what critics of the Purdue Pharma settlement get wrong; The Washington Post

Oct 27, 2020

If the purpose of litigation against opioid manufacturers is to help address the opioid crisis, then the Justice Department’s resolution of its investigation of Purdue should be hailed as a landmark settlement in the public interest. As victim advocates and public health experts have noted, the settlement can have a significant and positive impact.

featured-image_ORII-hands-01

Progress Over Perfection: The Secret to Success at the Children’s Center of Hamden

When it comes to teens navigating the issue of substance use and substance use disorder, The Children’s Center of Hamden in Connecticut knows that prioritizing realistic progress, offering teens alternatives, and providing the support to seek treatment services – on their own terms – makes all the difference.

featured-image_ORII-hands-01

Breaking Good”: Bringing Global Insights into Public Health Challenges in the US

How an optimistic problem solver and non-profit CEO is working with community organizations and non-profits to understand their most pressing challenges and connect them with resources to bring solutions to life.

featured-image_OSU-01

Working Together, Giving “More” in Oklahoma

Receiving from Purdue Pharma more than $100 million as part of a settlement of litigation brought by the state, the National Center for Wellness & Recovery (NCWR) at Oklahoma State University is remarkably positioned to accelerate work to address and abate the opioid crisis.

Privacy Policy Updates

Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parities’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through Your use of the Service, how we use it, how we share it, how we protect it, and the choices You can make about Your information.